艾盐包脐疗预防伊立替康所玫迟发性腹泻临床研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R7305.3;R244.9

基金项目:


Clinical Study on Aiyan Bag Navel Therapy for the Prevention of Delayed-onset Diarrhea Caused by Irinotecan
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察艾盐包脐疗预防伊立替康所致迟发性腹泻的效果。方法:将80例转移性结直肠癌患者随机分为对照组和治疗组各40例。对照组单纯接受含伊立替康化疗方案(FOLFIRI)化疗,不予以预防性处理;治疗组则在接受FOLFIRI化疗方案基础上,于化疗前1天开始予自制艾盐包脐疗处理。观察延迟性腹泻的发生率,比较化疗计划推迟情况,记录毒副作用发生情况。结果:与对照组迟发性腹泻发生率、严重性腹泻发生率47.50%、12.50%比较,治疗组的迟发性腹泻发生率、严重性腹泻发生率25.00%、2.50%降低,差异有统计学意义(P<0.05)。与对照组中断发生率、延迟发生率7.50%、25.00%比较,治疗组的中断发生率、延迟发生率0、7.50%降低,差异有统计学意义(P<0.05)。治疗组在治疗过程中恶心呕吐不良反应的发生率10.00%,低于对照组的27.50%,差异有统计学意义(P<0.05)。2组骨髓抑制、口腔溃疡、肝功能异常等方面的不良反应比较,差异无统计学意义(P>0.05)。结论:艾盐包脐疗预防伊立替康所致迟发性腹泻效果满意,提高化疗的顺应性,且能减少化疗后恶心呕吐的发生率。

    Abstract:

    Objective:To observe the effect of Aiyan bag navel therapy for the prevention of delayed-onset diarrhea caused by irinotecan.Methods:Divided 80 cases of patients with metastatic colorectal cancer into the control group and the treatment group randomly,with 40 cases in each group.The control group only received the chemotherapy according to the chemotherapy regimen including irinotecan(FOLFIRI),without being given the prophylactic treatment; while the treatment group was additionally treated with self-made Aiyan bag navel therapy since the day before chemotherapy.Observed the incidence of delayed-onset diarrhea,compared the delay of chemotherapy plan and recorded the occurrence condition of side effects.Results:Compared with 47.50% and 12.50% of the incidence of delayed-onset diarrhea and severe diarrhea in the control group,25.00% and 2.50% of the incidence of delayed-onset diarrhea and severe diarrhea in the treatment group was decreased,difference being significant(P<0.05).Compared with 7.50% and 25.00% of the incidence of interruption and delay in the control group,0 and 7.50% of the incidence of interruption and delay in the treatment group was decreased,difference being significant(P<0.05).During the treatment process,the incidence of adverse reactions of nausea and vomiting in the treatment group was 10.00%,being lower than that of 27.50% in the control group,difference being significant(P<0.05).There was no significant difference being found in the comparison of adverse reactions such as myelosuooression,oral ulcer and abnormal liver function in the two groups(P> 0.05).Conclusion:The application of Aiyan bag navel therapy for preventing delayed-onset diarrhea caused by irinotecan has satisfactory effect and it can improve the compliance of chemotherapy and reduce the incidence of nauseaand vomiting after chemotherapy.

    参考文献
    相似文献
    引证文献
引用本文

赖祥红.艾盐包脐疗预防伊立替康所玫迟发性腹泻临床研究[J].新中医,2020,52(1):83-85

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2020-01-06
  • 出版日期:
文章二维码